Top

Published in:

01-03-2021 | Sarcopenia | Original Research

Cutpoints for Muscle Mass and Strength Derived from Weakness or Mobility Impairment and Compared with Other Diagnostic Criteria in Community-Dwelling Elderly People

Authors: Hong-qi Xu, Jia-qi Sun, Yu Liu, Liao Tian, Jing-min Liu, Ji-peng Shi, Min Liu, Xiu-yuan Zheng

Published in: Calcified Tissue International | Issue 3/2021

Abstract

We identified the strength cutpoints concerning mobility impairment, then identified the muscle mass cutpoints concerning weakness, and compared the results with other diagnostic criteria to develop the clinical diagnostic criteria associated with functional impairment. In 7583 elderly people, classification and regression tree (CART) and receiver operating characteristic curve (ROC) analyses were used for determining cutpoints for handgrip strength (HGS) and appendicular lean mass (ALM) indices associated with slowness or weakness. Logistic regressions were then used to quantify the strength of the association between muscle mass (or strength) categories and weakness (or slowness). The CART second cutpoints of muscle mass and strength indices were lower than those specified by the ROC method and were between those cutpoints determined by the 20th and Mean-2SD methods. After adjusting for covariates, the associations remained significant in handgrip strength categories defined by the CART and ROC cutpoints and HGS/BMI categories defined by the CART, ROC, and 20th cutpoints in men and women (P < 0.05), ALM, ALM/Ht² categories defined by all four cutpoints (P < 0.05) and ALM/BMI categories defined by CART and ROC cutpoints in men (P < 0.05), and ALM and ALM/Ht² categories defined by the CART cutpoints in women (P < 0.05). Our approaches resulted in a definition of weak strength as handgrip strength or HGS/BMI less than 26.55 kg or 1.114 in men and less than 16.45 kg or 0.697 in women and then defined ALM, ALM/Ht², or ALM/BMI less than 18.92 kg, 7.08 kg/m², or 0.795 in men and less than 15.04 kg, 5.99 kg/m², or 0.517 in women as low lean mass.

Available only for authorised users

Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, Chou MY, Chen LY, Hsu PS, Krairit O, Lee JS, Lee WJ, Lee Y, Liang CK, Limpawattana P, Lin CS, Peng LN, Satake S, Suzuki T, Won CW, Wu CH, Wu SN, Zhang T, Zeng P, Akishita M, Arai H (2014) Sarcopenia in Asia: consensus report of the Asian working group for sarcopenia. J Am Med Dir Assoc 15:95–101. https://doi.org/10.1016/j.jamda.2013.11.025CrossRefPubMed

Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinkova E, Vandewoude M, Zamboni M, European Working Group on Sarcopenia in Older P (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing 39:412–423. https://doi.org/10.1093/ageing/afq034CrossRef

Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, Abellan van Kan G, Andrieu S, Bauer J, Breuille D, Cederholm T, Chandler J, De Meynard C, Donini L, Harris T, Kannt A, Keime Guibert F, Onder G, Papanicolaou D, Rolland Y, Rooks D, Sieber C, Souhami E, Verlaan S, Zamboni M (2011) Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 12:249–256. https://doi.org/10.1016/j.jamda.2011.01.003CrossRefPubMed

Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB, Ferrucci L, Guralnik JM, Fragala MS, Kenny AM, Kiel DP, Kritchevsky SB, Shardell MD, Dam TT, Vassileva MT (2014) The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A 69:547–558. https://doi.org/10.1093/gerona/glu010CrossRef

Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M, Writing Group for the European Working Group on Sarcopenia in Older P, the Extended Group for E (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:16–31. https://doi.org/10.1093/ageing/afy169CrossRef

Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, Jang HC, Kang L, Kim M, Kim S, Kojima T, Kuzuya M, Lee JSW, Lee SY, Lee WJ, Lee Y, Liang CK, Lim JY, Lim WS, Peng LN, Sugimoto K, Tanaka T, Won CW, Yamada M, Zhang T, Akishita M, Arai H (2020) Asian working group for Sarcopenia: 2019 consensus update on Sarcopenia diagnosis and treatment. J Am Med Dir Assoc 21(300–307):e302. https://doi.org/10.1016/j.jamda.2019.12.012CrossRef

McLean RR, Kiel DP (2015) Developing consensus criteria for sarcopenia: an update. J Bone Miner Res 30:588–592. https://doi.org/10.1002/jbmr.2492CrossRefPubMed

Cruz-Jentoft AJ, Sayer AA (2019) Sarcopenia. The Lancet 393:2636–2646. https://doi.org/10.1016/s0140-6736(19)31138-9CrossRef

Kim H, Hirano H, Edahiro A, Ohara Y, Watanabe Y, Kojima N, Kim M, Hosoi E, Yoshida Y, Yoshida H, Shinkai S (2016) Sarcopenia: prevalence and associated factors based on different suggested definitions in community-dwelling older adults. Geriatr Gerontol Int 16(Suppl 1):110–122. https://doi.org/10.1111/ggi.12723CrossRefPubMed

10.

Zeng P, Wu S, Han Y, Liu J, Zhang Y, Zhang E, Zhang Y, Gong H, Pang J, Tang Z, Liu H, Zheng X, Zhang T (2015) Differences in body composition and physical functions associated with sarcopenia in Chinese elderly: reference values and prevalence. Arch Gerontol Geriatr 60:118–123. https://doi.org/10.1016/j.archger.2014.08.010CrossRefPubMed

11.

Bai HJ, Sun JQ, Chen M, Xu DF, Xie H, Yu ZW, Bao ZJ, Chen J, Pan YR, Lu DJ, Cheng S (2016) Age-related decline in skeletal muscle mass and function among elderly men and women in Shanghai, China: a cross sectional study. Asia Pac J Clin Nutr 25:326–332. https://doi.org/10.6133/apjcn.2016.25.2.14CrossRefPubMed

12.

Kim YH, Kim KI, Paik NJ, Kim KW, Jang HC, Lim JY (2016) Muscle strength: a better index of low physical performance than muscle mass in older adults. Geriatr Gerontol Int 16:577–585. https://doi.org/10.1111/ggi.12514CrossRefPubMed

13.

Trombetti A, Reid KF, Hars M, Herrmann FR, Pasha E, Phillips EM, Fielding RA (2016) Age-associated declines in muscle mass, strength, power, and physical performance: impact on fear of falling and quality of life. Osteoporos Int 27:463–471. https://doi.org/10.1007/s00198-015-3236-5CrossRefPubMed

14.

Cawthon PM, Peters KW, Shardell MD, McLean RR, Dam TT, Kenny AM, Fragala MS, Harris TB, Kiel DP, Guralnik JM, Ferrucci L, Kritchevsky SB, Vassileva MT, Studenski SA, Alley DE (2014) Cutpoints for low appendicular lean mass that identify older adults with clinically significant weakness. J Gerontol A 69:567–575. https://doi.org/10.1093/gerona/glu023CrossRef

15.

Alley DE, Shardell MD, Peters KW, McLean RR, Dam TT, Kenny AM, Fragala MS, Harris TB, Kiel DP, Guralnik JM, Ferrucci L, Kritchevsky SB, Studenski SA, Vassileva MT, Cawthon PM (2014) Grip strength cutpoints for the identification of clinically relevant weakness. J Gerontol A 69:559–566. https://doi.org/10.1093/gerona/glu011CrossRef

16.

Charlier R, Knaeps S, Mertens E, Van Roie E, Delecluse C, Lefevre J, Thomis M (2016) Age-related decline in muscle mass and muscle function in Flemish Caucasians: a 10-year follow-up. Age (Dordr) 38:36. https://doi.org/10.1007/s11357-016-9900-7CrossRef

17.

McLean RR, Shardell MD, Alley DE, Cawthon PM, Fragala MS, Harris TB, Kenny AM, Peters KW, Ferrucci L, Guralnik JM, Kritchevsky SB, Kiel DP, Vassileva MT, Xue QL, Perera S, Studenski SA, Dam TT (2014) Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: the foundation for the National Institutes of Health (FNIH) sarcopenia project. J Gerontol A 69:576–583. https://doi.org/10.1093/gerona/glu012CrossRef

18.

Dam TT, Peters KW, Fragala M, Cawthon PM, Harris TB, McLean R, Shardell M, Alley DE, Kenny A, Ferrucci L, Guralnik J, Kiel DP, Kritchevsky S, Vassileva MT, Studenski S (2014) An evidence-based comparison of operational criteria for the presence of sarcopenia. J Gerontol A 69:584–590. https://doi.org/10.1093/gerona/glu013CrossRef

19.

Wang LM, Zhang M, Li YC, Huang ZJ, Deng Q, Zhao ZP, Li C, Zhou MG, Wang LH (2018) Scheme of the Chinese chronic non-communicable disease and risk factor surveillance. Zhonghua yu fang yi xue za zhi [Chin J Prev Med] 52:191–194. https://doi.org/10.3760/cma.j.issn.0253-9624.2018.02.015CrossRef

20.

Xu HQ, Shi JP, Shen C, Liu Y, Liu JM, Zheng XY (2018) Sarcopenia-related features and factors associated with low muscle mass, weak muscle strength, and reduced function in Chinese rural residents: a cross-sectional study. Arch Osteoporos 14:2. https://doi.org/10.1007/s11657-018-0545-2CrossRefPubMed

21.

Zeng P, Han Y, Pang J, Wu S, Gong H, Zhu J, Li J, Zhang T (2016) Sarcopenia-related features and factors associated with lower muscle strength and physical performance in older Chinese: a cross sectional study. BMC Geriatr 16:45–53. https://doi.org/10.1186/s12877-016-0220-7CrossRefPubMedPubMedCentral

22.

Xue C, Liu Y, Wang J, Zhang R, Zhang Y, Zhang J, Zhang Y, Zheng Z, Yu X, Jing H, Nosaka N, Arai C, Kasai M, Aoyama T, Wu J (2009) Consumption of medium- and long-chain triacylglycerols decreases body fat and blood triglyceride in Chinese hypertriglyceridemic subjects. Eur J Clin Nutr 63:879–886. https://doi.org/10.1038/ejcn.2008.76CrossRefPubMed

23.

McCarthy EK, Horvat MA, Holtsberg PA, Wisenbaker JM (2004) Repeated chair stands as a measure of lower limb strength in sexagenarian women. J Gerontol A 59:1207–1212. https://doi.org/10.1093/gerona/59.11.1207CrossRef

24.

Glenn JM, Gray M, Binns A (2017) Relationship of sit-to-stand lower-body power with functional fitness measures among older adults with and without sarcopenia. J Geriatr Phys Ther 40:42–50. https://doi.org/10.1519/JPT.0000000000000072CrossRefPubMed

25.

Smith WN, Del Rossi G, Adams JB, Abderlarahman KZ, Asfour SA, Roos BA, Signorile JF (2010) Simple equations to predict concentric lower-body muscle power in older adults using the 30-second chair-rise test: a pilot study. Clin Interv Aging 5:173–180. https://doi.org/10.2147/cia.s7978CrossRefPubMedPubMedCentral

26.

Institute of Medicine (2005) Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. The National Academies Press, Washington, DC

27.

Kim KM, Jang HC, Lim S (2016) Differences among skeletal muscle mass indices derived from height-, weight-, and body mass index-adjusted models in assessing sarcopenia. Korean J Intern Med 31:643–650. https://doi.org/10.3904/kjim.2016.015CrossRefPubMedPubMedCentral

28.

Chin KY, Soelaiman IN, Mohamed IN, Mohamed N, Shuid AN, Muhammad N, Wan Ngah WZ (2013) Discrepancy between the quantitative ultrasound value of Malaysian men and the manufacturer’s reference and the impact on classification of bone health status. J Clin Densitom 16:189–195. https://doi.org/10.1016/j.jocd.2012.03.004CrossRefPubMed

29.

Wong AM, Liu HL, Tsai ML, Schwartz ES, Yeh CH, Wang HS, Wu TW, Lin CY (2019) Arterial spin-labeling magnetic resonance imaging of brain maturation in early childhood: mathematical model fitting to assess age-dependent change of cerebral blood flow. Magn Reson Imaging 59:114–120. https://doi.org/10.1016/j.mri.2019.03.016CrossRefPubMed

30.

Li Y, Zou Z, Luo J, Ma J, Ma Y, Jing J, Zhang X, Luo C, Wang H, Zhao H, Pan D, Jia P (2020) The predictive value of anthropometric indices for cardiometabolic risk factors in Chinese children and adolescents: a national multicenter school-based study. PLoS ONE 15:e0227954. https://doi.org/10.1371/journal.pone.0227954CrossRefPubMedPubMedCentral

31.

Kim Y, Han BD, Han K, Shin KE, Lee H, Kim TR, Cho KH, Kim DH, Kim YH, Kim H, Nam GE (2015) Optimal cutoffs for low skeletal muscle mass related to cardiovascular risk in adults: the Korea national health and nutrition examination survey 2009–2010. Endocrine 50:424–433. https://doi.org/10.1007/s12020-015-0577-yCrossRefPubMed

32.

Chen LK, Lee WJ, Peng LN, Liu LK, Arai H, Akishita M, Asian Working Group for S (2016) Recent advances in sarcopenia research in Asia: 2016 update from the Asian working group for sarcopenia. J Am Med Dir Assoc 17(767):e761-767. https://doi.org/10.1016/j.jamda.2016.05.016CrossRef

33.

Leong DP, Teo KK, Rangarajan S, Kutty VR, Lanas F, Hui C, Quanyong X, Zhenzhen Q, Jinhua T, Noorhassim I, AlHabib KF, Moss SJ, Rosengren A, Akalin AA, Rahman O, Chifamba J, Orlandini A, Kumar R, Yeates K, Gupta R, Yusufali A, Dans A, Avezum A, Lopez-Jaramillo P, Poirier P, Heidari H, Zatonska K, Iqbal R, Khatib R, Yusuf S (2016) Reference ranges of handgrip strength from 125,462 healthy adults in 21 countries: a prospective urban rural epidemiologic (PURE) study. J Cachexia, Sarcopenia Muscle 7:535–546. https://doi.org/10.1002/jcsm.12112CrossRef

34.

Menant JC, Weber F, Lo J, Sturnieks DL, Close JC, Sachdev PS, Brodaty H, Lord SR (2017) Strength measures are better than muscle mass measures in predicting health-related outcomes in older people: time to abandon the term sarcopenia? Osteoporos Int 28:59–70. https://doi.org/10.1007/s00198-016-3691-7CrossRefPubMed

35.

Landi F, Calvani R, Tosato M, Martone AM, Fusco D, Sisto A, Ortolani E, Savera G, Salini S, Marzetti E (2017) Age-related variations of muscle mass, strength, and physical performance in community-dwellers: results from the milan EXPO survey. J Am Med Dir Assoc 18:88e17-88e24. https://doi.org/10.1016/j.jamda.2016.10.007CrossRef

36.

Edwards MH, Buehring B (2015) Novel approaches to the diagnosis of sarcopenia. J Clin Densitom 18:472–477. https://doi.org/10.1016/j.jocd.2015.04.010CrossRefPubMed

37.

Manini TM, Visser M, Won-Park S, Patel KV, Strotmeyer ES, Chen H, Goodpaster B, De Rekeneire N, Newman AB, Simonsick EM, Kritchevsky SB, Ryder K, Schwartz AV, Harris TB (2007) Knee extension strength cutpoints for maintaining mobility. J Am Geriatr Soc 55:451–457. https://doi.org/10.1111/j.1532-5415.2007.01087.xCrossRefPubMed

38.

Marsh AP, Miller ME, Saikin AM, Rejeski WJ, Hu N, Lauretani F, Bandinelli S, Guralnik JM, Ferrucci L (2006) Lower extremity strength and power are associated with 400-meter walk time in older adults: the InCHIANTI study. J Gerontol A 61:1186–1193. https://doi.org/10.1093/gerona/61.11.1186CrossRef

39.

Studenski S, Perera S, Patel K, Rosano C, Faulkner K, Inzitari M, Brach J, Chandler J, Cawthon P, Connor EB, Nevitt M, Visser M, Kritchevsky S, Badinelli S, Harris T, Newman AB, Cauley J, Ferrucci L, Guralnik J (2011) Gait speed and survival in older adults. JAMA 305:50–58. https://doi.org/10.1001/jama.2010.1923CrossRefPubMedPubMedCentral

40.

Peel NM, Kuys SS, Klein K (2013) Gait speed as a measure in geriatric assessment in clinical settings: a systematic review. J Gerontol A 68:39–46. https://doi.org/10.1093/gerona/gls174CrossRef

41.

Zacharis NZ (2018) Classification and regression trees (CART) for predictive modeling in blended learning. Int J Intel Syst Appl 10:1–9. https://doi.org/10.5815/ijisa.2018.03.01CrossRef

42.

Cheng Q, Zhu X, Zhang X, Li H, Du Y, Hong W, Xue S, Zhu H (2014) A cross-sectional study of loss of muscle mass corresponding to sarcopenia in healthy Chinese men and women: reference values, prevalence, and association with bone mass. J Bone Miner Metab 32:78–88. https://doi.org/10.1007/s00774-013-0468-3CrossRefPubMed

43.

Delmonico MJ, Harris TB, Lee JS, Visser M, Nevitt M, Kritchevsky SB, Tylavsky FA, Newman AB, Health A, Body Composition S (2007) Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc 55:769–774. https://doi.org/10.1111/j.1532-5415.2007.01140.xCrossRefPubMed

Title: Cutpoints for Muscle Mass and Strength Derived from Weakness or Mobility Impairment and Compared with Other Diagnostic Criteria in Community-Dwelling Elderly People
Authors: Hong-qi Xu
Jia-qi Sun
Yu Liu
Liao Tian
Jing-min Liu
Ji-peng Shi
Min Liu
Xiu-yuan Zheng
Publication date: 01-03-2021
Publisher: Springer US
Keyword: Sarcopenia
Published in: Calcified Tissue International / Issue 3/2021
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI: https://doi.org/10.1007/s00223-020-00778-0

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2021

The Dysregulated Galectin Network Activates NF-κB to Induce Disease Markers and Matrix Degeneration in 3D Pellet Cultures of Osteoarthritic Chondrocytes

Secreted Phosphoprotein 24 is a Biomarker of Mineral Metabolism

Relationships Between Level and Change in Sarcopenia and Other Body Composition Components and Adverse Health Outcomes: Findings from the Health, Aging, and Body Composition Study

Genetically Predicted Sex Hormone-Binding Globulin and Bone Mineral Density: A Mendelian Randomization Study

Genotype–Phenotype Associations in 72 Adults with Suspected ALPL-Associated Hypophosphatasia

High-Resolution Cone-Beam Computed Tomography is a Fast and Promising Technique to Quantify Bone Microstructure and Mechanics of the Distal Radius

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials